CD44 and melanoma: Furthermore, Boisgerault et al. demonstrated that in prostate cancer, topoisomerase IIα and CD44 are antigens which are specific to M-like cells, and further showed that a subset of melanoma cells also expressed topoisomerase IIα (29, 30).